Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Export Driven Multidisciplinary Approach Wins EFF Manufacturing Award for 2011

By LabMedica International staff writers
Posted on 30 Nov 2011
Binding Site (Birmingham, UK), a developer and producer of laboratory based tests for the diagnosis and monitoring of blood cancers and immunodeficiency diseases, won the EEF (Engineering Employers Federation) Midlands Outstanding Export Award, sponsored by the UKTI (UK Trade and Investment). More...


Binding Site’s export strategy has been developed and refined for more than ten years to become integral to all aspects of the business. Initially, the export initiative was led by the sales and marketing team, but as overseas expansion gathered pace, the company drew on the support of technical, R&D, human resources, and finance departments. As a result of this multidisciplinary approach, Binding Site currently exports around 90% of its products – with the United States accounting for 47% of total sales.

The annual awards are hosted by EEF, the manufacturers’ organization, and recognize excellence in enterprise, innovation, environmental performance, and skills development among UK manufacturers. Richard Halstead, EEF Midlands Regional Director, said, “Manufacturing is crucial to our region’s economic recovery. Companies like Binding Site are leading the way by taking a research-led approach to developing niche export markets for high value, knowledge-based products. Congratulations to them on this well deserved success.”

Binding Site will go forward to compete against other regional winners from across the UK in EEF’s National Awards final, to take place on January 26, 2012, in London (UK).

Related Links:
Binding Site



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.